Serum from the NiV-M survivors was found to contain measurable NiV-specific IgG and IgM antibodies within 2 weeks after exposure, and the clearance of NiV from blood and swabs at 2 weeks indicated the elicitation of virus-specific antibody in response to the infection. The gene discussed is CD40LG; the disease is infection.